Economic Overview - In the week of July 14-18, 2025, China's GDP growth rate for the first half of the year reached 5.3%, solidifying the foundation for annual economic growth [1] - Major A-share indices continued to rebound, with the Shanghai Composite Index stabilizing above 3500 points, and daily trading volume remaining high [1] ETF Performance - The average increase of all ETFs in the market was 1.87%, driven by the strong performance of the technology sector, with stock ETFs rising by 1.75% [1] - The top-performing ETFs in the pharmaceutical sector saw significant gains, with the Hang Seng Innovation Drug ETF rising by 13.69% [2] Sector Insights - The biotech sector in China is entering a structural revaluation phase, with the overall market capitalization of Chinese biotech companies at only 14%-15% of their U.S. counterparts, despite contributing nearly 33% to global innovation [3] - The adjustment of the medical insurance directory and commercial health insurance for innovative drugs is expected to provide stronger economic support for the development of innovative drugs [3] Fund Flows - For the period of July 14-17, 2025, the ETF market saw a net inflow of 401.73 billion yuan, with bond ETFs leading the inflow at 531.30 billion yuan [6] - The top inflow ETFs included the Huaxia Sci-Tech Bond ETF, which attracted 112.20 billion yuan [8] Trading Activity - The Short-term Bond ETF recorded a weekly trading volume of 710.02 billion yuan, leading the market [10] - The overall trading activity in bond funds remained high, indicating strong investor interest [10] Upcoming Listings - A new ETF, the Huatai-PineBridge Hong Kong Stock Connect Consumer Theme ETF, is set to launch, focusing on a higher purity of consumption sectors, including food and beverage, textiles, and household appliances [11]
ETF市场周报 | GDP维持高增速!科技赛道捷报频传,科创债ETF获大资金加持
Sou Hu Cai Jing·2025-07-18 10:11